Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation.
about
The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantationMesenchymal stem cells: immune evasive, not immune privilegedImmunoregulation by mesenchymal stem cells: biological aspects and clinical applicationsMesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.Mesenchymal stem cells detect and defend against gammaherpesvirus infection via the cGAS-STING pathway.Could cancer and infection be adverse effects of mesenchymal stromal cell therapy?Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical applicationRecent progress in managing graft-versus-host disease and viral infections following allogeneic stem cell transplantation.Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system.Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease--friends or foes?Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseasesMesenchymal stromal cells in renal transplantation: opportunities and challenges.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies.Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis.Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation.Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome.General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home care.Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.The Effect of Mesenchymal Stem Cell-Derived Extracellular Vesicles on Hematopoietic Stem Cells Fate.The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses.The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic Review
P2860
Q26748595-FE0E93C2-7B9B-48E8-B7C6-F602EAFA635DQ27003371-45CAAD85-BB4B-472F-ADD8-E3A6BE22D779Q27026892-DB746D53-CAF3-43D0-9159-0B7695318B88Q33755190-735CC264-C9B9-4C0A-959E-8914A39424ADQ34294935-50CB83F1-BFBE-43DE-8582-8744DDB981C0Q34975235-890CB13C-5293-48DE-8D2B-7BC82A4018A9Q35205677-470AE8FA-8389-493E-9612-402000A5326EQ36998274-07151183-069E-463E-BEBC-168A59A08790Q38066586-E116BC7C-803D-49D2-831B-C94DC985BF8CQ38098448-2C73149E-134A-4230-B199-5074C94989F1Q38206879-E674FD66-2AC3-4BE4-BDAC-F3EA543D4769Q38291498-46A7A7ED-0E96-457E-887E-241B6A97F56AQ38725481-CBACB217-D836-46E9-979F-17FBB1BD749AQ39012031-FB226D00-0435-49AE-9F45-F6A81D1CAEAAQ40119705-7D4B463C-2875-43A8-AD6A-B5440EADF4B0Q40592185-5F019456-3583-4E08-A969-A684CDE7089AQ41193110-74E593FA-9318-4503-8B1F-06C80253C30EQ41290373-B38439D8-B347-4143-97F1-4434F391E41EQ43988469-E55490F8-DB1D-45AE-867B-91F7E3E011E5Q48295098-BE055C77-C656-42D0-9D2F-67F454E8F2B0Q49332525-81D50BBB-FFF7-4F39-BFD2-A455547C65CDQ51659017-FBABE01D-C5DF-409C-82E7-02DC228496FEQ57538743-1871D113-23DE-4DAE-8E12-86980B9C7164
P2860
Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Treatment with mesenchymal str ...... tic stem cell transplantation.
@en
Treatment with mesenchymal str ...... tic stem cell transplantation.
@nl
type
label
Treatment with mesenchymal str ...... tic stem cell transplantation.
@en
Treatment with mesenchymal str ...... tic stem cell transplantation.
@nl
prefLabel
Treatment with mesenchymal str ...... tic stem cell transplantation.
@en
Treatment with mesenchymal str ...... tic stem cell transplantation.
@nl
P2093
P2860
P1476
Treatment with mesenchymal str ...... tic stem cell transplantation.
@en
P2093
Britt Gustafsson
Katarina LeBlanc
Mats Remberger
Ola Blennow
Olle Ringdén
Ulrica Forslöw
P2860
P304
P356
10.1111/J.1600-0609.2012.01824.X
P577
2012-09-01T00:00:00Z